Clinical Trial Update: Cabozantinib in Advanced Adrenocortical Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cabozantinib for advanced adrenocortical carcinoma is ongoing, with no results or status information provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Wuerzburg University Hospital | Conditions: Adrenocortical Carcinoma | Phase 2 | Status: UNKNOWN